Lifespan Edge, a next-generation longevity clinic co-founded by futurist John Mauldin and preventive medicine pioneer Dr. Michael Roizen, has announced the opening of two new locations in West Palm Beach, Florida, and Columbia, Maryland, with a third premier destination planned for Scottsdale, Arizona. The expansion marks a significant step in the company's mission to make personalized, evidence-based longevity care more accessible.
Founded in 2024, Lifespan Edge aims to bridge cutting-edge longevity research with individualized clinical care for individuals seeking to optimize healthspan, cognitive vitality, and quality of life. Dr. Michael Roizen, Chair of the Board and Co-Founder, emphasized that healthcare should begin decades before disease appears, focusing on modifiable factors that influence aging. Through personalized care, informed lifestyle choices, and emerging scientific advances, the clinic empowers individuals to take greater control of their long-term health.
The new locations include West Palm Beach, Florida (2528 Okeechobee Blvd., West Palm Beach, FL 33409) and Columbia, Maryland (10700 Charter Drive, Suite 200, Columbia, MD 21044). A premier luxury wellness destination is coming soon to Scottsdale, Arizona, designed to serve clients from across the United States and abroad. Each clinic offers a concierge-style experience combining advanced diagnostics, physician-guided evaluations, and personalized strategies focused on prevention, performance, and healthy aging.
Interest in longevity medicine has accelerated as consumers increasingly seek proactive approaches to maintaining cognitive function, metabolic health, physical resilience, and overall vitality. Lifespan Edge emphasizes identifying risk factors early and creating individualized plans that support long-term wellness, rather than focusing solely on treating disease after symptoms arise. John Mauldin, President and Co-Founder, believes this represents a fundamental evolution in healthcare, translating science into practical strategies for healthier, more productive lives.
Among the scientific areas attracting attention is Therapeutic Plasma Exchange (TPE), a medical procedure with established clinical uses that is being investigated for potential applications related to aging and neurodegenerative disease. Notable research includes the AMBAR (Alzheimer Management by Albumin Replacement) clinical trial, which evaluated plasma exchange with albumin replacement in patients with mild-to-moderate Alzheimer’s disease. Published findings reported that the intervention showed promise in slowing decline in certain cognitive and functional measures, though additional research is needed. Dr. Roizen noted that the most exciting developments in longevity are helping us understand how the body repairs itself, and Lifespan Edge follows the science, personalizes care, and continually evaluates new evidence.
Dr. Roizen has long advocated that biological age and chronological age are not always the same, emphasizing that lifestyle choices—including nutrition, physical activity, stress management, purpose, and social connection—can meaningfully influence long-term health. He believes prevention should remain the foundation of modern medicine, as daily decisions profoundly affect future health.
The expansion of Lifespan Edge comes amid growing national recognition for its leadership. Dr. Roizen was recently featured in Entrepreneur and TopDoctor Magazine, where he shared his philosophy that persistence, prevention, and personalized care can reshape healthcare and redefine aging. With additional locations planned, Lifespan Edge aims to help redefine aging by providing evidence-informed strategies for longer, healthier, and more active lives.
